BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22763984)

  • 1. Structure-activity studies on the fluorescent indicator in a displacement assay for the screening of small molecules binding to RNA.
    Umemoto S; Im S; Zhang J; Hagihara M; Murata A; Harada Y; Fukuzumi T; Wazaki T; Sasaoka S; Nakatani K
    Chemistry; 2012 Aug; 18(32):9999-10008. PubMed ID: 22763984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
    Peterson RD; Feigon J
    J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
    Wang Y; Hamasaki K; Rando RR
    Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative dimerization of a stably folded protein directed by a flexible RNA in the assembly of the HIV Rev dimer-RRE stem II complex.
    Tanamura S; Terakado H; Harada K
    J Mol Recognit; 2016 May; 29(5):199-209. PubMed ID: 26620599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
    Charpentier B; Stutz F; Rosbash M
    J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native mass spectrometry reveals the initial binding events of HIV-1 rev to RRE stem II RNA.
    Schneeberger EM; Halper M; Palasser M; Heel SV; Vušurović J; Plangger R; Juen M; Kreutz C; Breuker K
    Nat Commun; 2020 Nov; 11(1):5750. PubMed ID: 33188169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct mass spectrometric determination of the stoichiometry and binding affinity of the complexes between nucleocapsid protein and RNA stem-loop hairpins of the HIV-1 Psi-recognition element.
    Hagan N; Fabris D
    Biochemistry; 2003 Sep; 42(36):10736-45. PubMed ID: 12962498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent ligand as a molecular probe for the RNA structure.
    Umemoto S; Zhang J; Dohno C; Nakatani K
    Nucleic Acids Symp Ser (Oxf); 2008; (52):211-2. PubMed ID: 18776328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring the peptide-binding specificity of an RNA by combinations of specificity-altering mutations.
    Sugaya M; Nishimura F; Katoh A; Harada K
    Nucleosides Nucleotides Nucleic Acids; 2008 May; 27(5):534-45. PubMed ID: 18569791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of HIV Rev peptides containing peptide nucleic acid that bind HIV RRE IIB RNA.
    Kumagai I; Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem Lett; 2000 Feb; 10(4):377-9. PubMed ID: 10714504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent indicator displacement assay for ligand-RNA interactions.
    Zhang J; Umemoto S; Nakatani K
    J Am Chem Soc; 2010 Mar; 132(11):3660-1. PubMed ID: 20196592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
    Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
    Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
    Pallesen J; Dong M; Besenbacher F; Kjems J
    FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent indicator displacement assay of ligands targeting 10 microRNA precursors.
    Murata A; Harada Y; Fukuzumi T; Nakatani K
    Bioorg Med Chem; 2013 Nov; 21(22):7101-6. PubMed ID: 24084297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.